Dana-Farber Cancer Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Dana-Farber Cancer Institute
Nov 30, 2024, 16:39 | Blog
Registration is open for Part III of the AORTIC North America Series
AORTIC Africa shared a post on LinkedIn: "Have you registered for Part III of the…
Nov 30, 2024, 15:58 | Blog
Dana-Farber - Changing how outcomes of clinical trials are shared with patients by publishing summaries of trials
Dana-Farber shared on X: "The Breast Oncology Program is changing how outcomes of clinical trials are…
Nov 26, 2024, 13:22 | Blog
David Jackman addresses common lung cancer risk factors - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Smokers have a 20-fold increase in the…
Nov 25, 2024, 18:03 | Insight
Rutika Mehta: The 2nd Annual GI Cancer Summit
Rutika Mehta, Associate Professor at Weill Cornell Medicine, shared a post on X: “Thanks to…
Nov 25, 2024, 15:59 | Blog
Gastric Cancer Awareness Month 2024
November is Gastric Cancer Awareness Month, a time to raise awareness about gastric (stomach) cancer.…
Nov 24, 2024, 08:53 | Blog
Coleman Lindsley: Faculty position open at Dana-Farber Cancer Institute
Coleman Lindsley, Physician-Scientist at Dana-Farber Cancer Institute, shared the following on X: “We just opened a…
Nov 22, 2024, 17:22 | Insight
Chiara Corti: Estrogen Signaling in Early-Stage Breast Cancer
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “I am…
Nov 20, 2024, 15:43 | Blog
Parts of The AORTIC North America Series - AORTIC- Africa
AORTIC- Africa shared a post on LinkedIn: "The AORTIC North America Series continues on 3 December…
Nov 20, 2024, 10:18 | Blog
Andrew Lane received the 2024 David M. Livingston Collaboration Award
Dr. Andrew A. Lane of Dana-Farber Cancer Institute was recognized with the David M. Livingston…
Nov 18, 2024, 16:36 | Insight
Very last chance to apply for the CancerX Accelerator Startup
CancerX Moonshot shared a post on LinkedIn: “Due tomorrow! This is your very last chance…
Nov 17, 2024, 09:56 | Blog
Toni Choueiri received the Lifetime Achievement Award at The King Hussein Cancer Foundation Annual Celebration
Toni Choueiri from Dana-Farber Cancer Institute Honored with Lifetime Achievement Award at The King Hussein…
Nov 17, 2024, 07:33 | Blog
Toni Choueiri: Honored by the King Hussein Cancer Foundation
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute,…
Nov 16, 2024, 20:35 | Insight
Kate Dibble: Financial Difficulty Over Time in Young Adults With Breast Cancer
Kate Dibble, Instructor of Medicine at Dana-Farber Cancer Institute, shared a post on X about…
Nov 14, 2024, 13:02 | Blog
Chiara Corti: We are officially oncologists!
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Today, after…
Nov 13, 2024, 11:25 | Blog
Some information you should know about lung cancer - American Cancer Society
American Cancer Society shared on LinkedIn: "Some information you should know about lung cancer, from Dr.…
Nov 11, 2024, 04:28 | Blog
Dana-Farber Cancer Institute supports breast cancer equity legislation in Massachusetts
Dana-Farber Cancer Institute shared a post on LinkedIn: "This week, the state Legislature passed a…
Nov 11, 2024, 03:28 | Dialogues
Beyond the Cancer Diagnosis: Dialogue with Sue Morris, by Adrian Pogacian
In this edition of "Beyond the Cancer Diagnosis", Adrian Pogacian interviews clinical psychologist Sue Morris…
Nov 10, 2024, 15:29 | Blog
Save the date for the 22nd SIO International Conference
Society for Integrative Oncology posted on X: "Save the date! SIO is excited to partner…
Nov 9, 2024, 20:08 | Blog
Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared the following on X: “Dr. Sara Tolaney discussed ESMO24 Insights…
Nov 9, 2024, 10:21 | Blog
Toni Choueiri: Our recent perspective on the next therapies in immuno-oncology trials
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, posted…
Nov 8, 2024, 13:58 | Blog
Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…
Nov 8, 2024, 12:37 | Positive
Jennifer Buell: Pioneering Leadership in Biotechnology
Dr. Jennifer Buell is a prominent figure in the biotechnology industry, currently serving as the…
Nov 7, 2024, 15:50 | Insight
Endometrial Cancer Advances - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "For the past decade, new cases of endometrial…
Nov 6, 2024, 14:55 | Insight
Dana Farber Cancer Institute’s 7th Annual Inflammatory Breast Cancer Patient Forum
Dana-Farber’s Breast Oncology Center shared a post on X: “Join us on Saturday November 9…
Nov 6, 2024, 12:05 | Blog
Karl Semaan: Landscape of subsequent therapies in perioperative immunotherapy trials
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, posted on X about recent…
Nov 4, 2024, 10:04 | Blog
Toni Choueiri: Cathy Wu and Patrick Ott were recognized as 2 of the leading cancer researchers by STAT
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute…
Nov 2, 2024, 12:01 | Positive
Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…
Oct 31, 2024, 16:35 | Blog
Does vaping increase your risk of cancer? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Does vaping increase your risk of cancer?…
Oct 31, 2024, 08:36 | Blog
2024 Hamburg Awardees for Advances in Biomedical Research and Clinical Medicine - Dana-Farber Cancer Institute
Recently, Gordon Freeman and Arlene Sharpe Received the Hamburg Award from the National Academy of…
Oct 27, 2024, 09:14 | Blog
invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, announced that the…
Oct 27, 2024, 08:17 | Blog
The 25th anniversary of pioneering Adult and Pediatric Patient and Family Advisory Councils - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: ''Last week we celebrated the 25th anniversary…
Oct 24, 2024, 17:26 | Blog
Recognizing Inflammatory Breast Cancer Awareness Day - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Today, Dr. Filipa Lynce, director of the Inflammatory…
Oct 24, 2024, 14:11 | Blog
How can you reduce your risk of cancer? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted the following on LinkedIn: “If you’ve had a history of sunburns,…
Oct 23, 2024, 15:41 | Career
Matthew Vander Heiden is elected as a member of the National Academy of Medicine
Matthew Vander Heiden, Director of the Koch Institute for Integrative Cancer Research at MIT, was…
Oct 22, 2024, 23:13 | Blog
Announcing the 2025 CancerX Accelerator Program - CancerX Moonshot
CancerX Moonshot shared a post on LinkedIn: ''Announcing the 2025 CancerX Accelerator Program! This year,…
Oct 20, 2024, 18:47 | Blog
Tochukwu Njoku: A journey from uncertainty to confidence at Dana-Farber
Dana-Farber Cancer Institute shared the following on LinkedIn: “For Tochukwu Njoku, a period that started…
Oct 18, 2024, 15:17 | Drugs
Duffy - Null phenotype's impact on Cancer Drug Trials - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on Linkedin: '' Many clinical trials of new cancer drugs may…
Oct 17, 2024, 05:56 | Blog
Jun Mao: Amazing integrative medicine medical consult model of care Dana-Farber’s Breast Oncology Center
Jun Mao, Professor of Medicine at Weill Cornell Medicine, shared a post on X: “Seeing…
Oct 16, 2024, 17:00 | Insight
Biagio Ricciuti: 5-year update from the NADIM trial
Biagio Ricciuti shared a post on X about a recent paper by Mariano Provencio et…
Oct 16, 2024, 12:52 | Blog
Sylvia Bartel is the new senior vice president of pharmacy and chief pharmacy officer at Dana-Farber Cancer Institute
Sylvia Bartel is the chief pharmacy officer and senior vice president of pharmacy at the…
Oct 12, 2024, 17:13 | Career
Monica Bertagnolli: Humbled to become a Knight of the Order of Merit of the Republic of Italy
Monica Bertagnolli shared a post on LinkedIn: "I was humbled to recently receive the honor…
Oct 12, 2024, 00:58 | Blog
SIO partner with Dana Farber Cancer Institute in hosting the 22nd SIO International Conference
Society for Integrative Oncology (SIO) shared on X: '' Save the date! SIO is excited to…
Oct 11, 2024, 14:37 | Insight
U.S. FDA approved nivolumab with platinum-doublet chemotherapy
Toni Choueiri shared a post on X: "JUST IN: US_FDA approved nivolumab with platinum-doublet chemotherapy…
Oct 10, 2024, 06:38 | Insight
Guilherme Nader Marta: The impact of low levels of HER2 expression in the Ph3 PALLAS trial
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, recently shared about the Ph3 PALLAS…
Oct 9, 2024, 14:32 | Career
Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair
Toni Choueiri shared a post about Eli Van Allen. Read his post on X below:…
Oct 9, 2024, 12:04 | Blog
Dana-Farber/Boston Children's ranked among the best pediatric cancer programs in the nation for 18th year in a row
Dana-Farber/Boston Children's Hospital Cancer and Blood Disorder Center has been recognized as one of the…
Oct 8, 2024, 12:41 | Blog
The Ending Metastatic Breast Cancer for Everyone Program - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X: "Join Kristina Fanucci, MD, and Antonio Giordano, MD, PhD,…
Oct 7, 2024, 18:24 | Blog
Toni Choueiri: The mood for the 2024 The Jimmy Fund walk
Toni Choueiri shared a post on LinkedIn: "The mood in Hopkinton who is hosting us…
Oct 7, 2024, 17:05 | Blog
CRISPR-based mouse model for VHL-deficient clear cell kidney cancer shows promise, suggested by Yüksel Ürün
Yüksel Ürün shared an article by Laura A Stransky on X: "A new CRISPR-based mouse…
Oct 7, 2024, 11:35 | Blog
Carla Tardif: Children with cancer from low-income households are three times more likely to die and two times more likely to relapse than their counterparts
Carla Tardif shared a post on LinkedIn, about recent article published on her LinkedIn: ''Parents…
Oct 6, 2024, 17:16 | Blog
Do cancers always have a genetic component? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on X: "Do cancers always have a genetic component?…
Oct 6, 2024, 15:28 | Insight
Revolutionizing Cancer Research: The Launch of the Cancer AI Alliance
Fred Hutch President Thomas Lynch announced the Cancer AI Alliance at the Madrona IA (Intelligent…
Oct 5, 2024, 16:52 | Blog
Breastfeeding experiences among young Breast Cancer survivors - ACS Journal Cancer
ACS Journal Cancer posted on X about recent paper by Tal Sella et al., titled…
Oct 5, 2024, 08:38 | Blog
Kimia Sorouri: Excited to be speaking at ASRM24
Kimia Sorouri, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Excited to…
Oct 4, 2024, 15:15 | Blog
Paolo Tarantino: An interesting biomarker study of DB04. Two notable findings at ESMO24
Paolo Tarantino shared a post on X: "Among the many great ESMO24 posters there was…
Oct 4, 2024, 15:09 | Blog
Phase 3 EVER-002 trial is out
Paolo Tarantino shared an article by Binghe Xu on X: "Phase 3 EVER-002 trial (also…
Oct 3, 2024, 17:56 | Career
Benjamin Ebert: Honored to begin my tenure as President and CEO of Dana-Farber Cancer Institute
Benjamin Ebert shared a post on LinkedIn: "I am honored to begin my tenure today…
Oct 1, 2024, 17:18 | Blog
Paolo Tarantino: Feels like yesterday when I first stepped into Dana-Farber Cancer Institute
Paolo Tarantino shared a post on X: "It feels like yesterday when I first stepped…
Oct 1, 2024, 11:39 | Blog
Marlise R. Luskin: Severe neutropenia is associated with blinatumomab
Marlise R. Luskin, leukemia specialist at Dana-Farber Cancer Institute, posted on X: "Severe neutropenia is…
Oct 1, 2024, 10:45 | Insight
Jennifer Thalappillil: First session of the Colorectal Club at the Dana Farber Cancer Institute
Jennifer Thalappillil, Scientific Writer at Dana-Farber Cancer Institute, shared a post on X: “Today we…
Sep 29, 2024, 12:53 | Blog
31 Hispanic and Latino leaders to know in 2024
Becker's released a list honoring Hispanic and Latino healthcare leaders. Diverse leadership in healthcare enhanced…
Sep 28, 2024, 15:22 | Blog
Patient advocates join panel on early detection and screening at AACRdisp24
AACR shared the following on X: “Patient advocates Ivis Febus-Sampayo and Aki Smith joined the…
Sep 28, 2024, 14:00 | Blog
Paolo Tarantino: How do the results of DESTINY-Breast06 change our practice?
Paolo Tarantino shared on LinkedIn: "How do the results of DESTINY-Breast06 change our practice? Should…
Sep 27, 2024, 18:57 | Insight
Danielle Bitterman: Our study on LLMs for patient portal messaging featured on The New Yourk Times
Danielle Bitterman shared a post on LinkedIn: "Proud to see the The New York Times…
Sep 24, 2024, 07:26 | Societies
29 Oncology Professionals Have Received A Conquer Cancer Merit Award
The Conquer Cancer Merit Award is a prestigious recognition given by the Conquer Cancer Foundation,…
Sep 23, 2024, 15:50 | Insight
Guru Sonpavde: ESMO24 bladder cancer practice-changing highlight
Guru Sonpavde, Genitourinary Oncology and Phase I Clinical Trials Director of Chair of Bladder Cancer…
Sep 21, 2024, 20:26 | Blog
Dana-Farber Cancer Institute celebrates passage of the Accelerating Kids' Access to Care Act by the U.S. House of Representatives
Laurie Glimcher shared on X: "Dana-Farber Cancer Institute celebrates passage of the Accelerating Kids' Access…
Sep 20, 2024, 13:12 | Blog
Wafik S. El-Deiry: Dr. Matt Meyerson speaks at Dana-Farber symposium
Wafik S. El-Deiry posted the following on LinkedIn: “Dr. Matt Meyerson at Dana-Farber Cancer Institute…
Sep 20, 2024, 13:00 | Blog
The 1st webinar of the ’24-‘25 EMBRACE Metastatic Breast Cancer Forum Series - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on X: ''Join Nancy Lin, and Sara Tolaney, via Zoom for…
Sep 19, 2024, 19:49 | Career
Ann Partridge has been named Interim Chair of Medical Oncology for Dana-Farber
Dr. Ann H. Partridge, MD, MPH, is a prominent medical oncologist specializing in breast cancer.…
Sep 19, 2024, 08:59 | Insight
Fantastic talk by Toni Choueiri at ESMO2024 on Ti-Nivo2 trial
Petros Grivas shared a post by Yüksel Ürün on X, adding: "Fantastic talk by brilliant Toni Choueiri…
Sep 18, 2024, 11:25 | Insight
Toni Choueiri: PEACE-3 phase 3 trials first results at ESMO24
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X by…
Sep 14, 2024, 12:17 | Blog
OncoInfluencers to Follow on Social Media: Dr. Monica Bertagnolli
We are thrilled to spotlight Dr. Monica Bertagnolli as a significant figure in the oncology…
Sep 13, 2024, 07:45 | Blog
Harold J. Burstein: Important story on cancer toll among Latinos featuring Narjust Florez
Harold J. Burstein, Breast cancer specialist and Professor at Dana-Farber Cancer Institute, shared a post on…
Sep 12, 2024, 09:57 | Insight
Meta-analysis of 20 RCTs with 14,995 Metastatic Castrate-sensitive Prostate Cancer patients
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer Institute, shared…
Sep 11, 2024, 10:52 | Blog
Thejus Jayakrishnan: My first faculty retreat at Dana-Farber Cancer Institute
Thejus Jayakrishnan, Gastrointestinal Oncologist at Dana-Farber Cancer Institute, shared a post on X: ''Had a…
Sep 10, 2024, 18:42 | Blog
Roupen Odabashian: Whole-Body MRI: A Comprehensive Approach to Cancer Screening with Growing Potential and Challenges
Roupen Odabashian posted on LinkedIn: "Disclaimer: My name is Roupen, and I am an Oncologist…
Sep 10, 2024, 13:52 | Career
Antonio Giordano: Excited to welcome Dr. Benjamin Ebert as next CEO of Dana Farber Cancer Institute
Antonio Giordano, President of Sbarro Health Research Organization, shared a post by The Boston Globe,…
Sep 8, 2024, 07:49 | Insight
Dana-Farber’s Breast Cancer in Young Adults Forum hosted by Ann Partridge
Dana-Farber’s Breast Oncology Center shared on X: “Join us on Oct 18th for the Breast…
Sep 8, 2024, 02:35 | Career
The New President and CEO of Dana-Farber Cancer Center - Benjamin Ebert
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center…
Sep 7, 2024, 19:36 | Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 7, 2024, 15:31 | Insight
Potential drug to target a rare childhood brain tumour - ICR
The Institute of Cancer Research (ICR) shared a post on LinkedIn: "News: Research reveals a…
Sep 7, 2024, 11:44 | Insight
Toni Choueiri: Celebrating Matt Freedman, the new David Goldstein Chair at Dana-Farber Cancer Institute
Toni Choueiri shared on X: “A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman,…
Sep 6, 2024, 13:28 | Insight
Biagio Ricciuti: How adaptive mechanisms and increased GTP loading confer resistance to KRAS G12C OFF
Biagio Ricciuti shared on X: “Our in Nature Communications our collaborative effort showing how adaptive mechanisms…
Sep 6, 2024, 13:23 | Dialogues
Liposarcoma Advances and Challenges - Sarcoma Talk #9 with Vinayak Venkataraman
In this edition of Sarcoma Talk on OncoDaily, Dr. Vinayak Venkataraman, a medical oncologist from…
Sep 6, 2024, 12:30 | Career
Mikkael A. Sekeres, Candidate for Secretary of ASH
Mikkael A. Sekeres, Chair of Committee on Communications at American Society of Hematology (ASH) is…
Sep 6, 2024, 02:23 | Insight
Gustavo Alencastro Veiga Cruzeiro: Diffuse hemispheric glioma, H3G34R/V-mutant
Mara Vinci, Chair of Biology SIOPE HGG Working Group, shared a post by Gustavo Alencastro…
Sep 5, 2024, 19:21 | Insight
Mariella Filbin: Our latest paper on pediatric/AYA glioma
Mariella Filbin shared a post on X by Gustavo Cruzeiro about a recent paper by…
Sep 5, 2024, 15:22 | Blog
Paolo Tarantino: Looking forward to join the Medscape symposium to review treatment landscape for HR+/HER2- metastatic breast cancer
Paolo Tarantino shared a post on LinkedIn: "Really looking forward to joining this Medscape symposium to…
Sep 5, 2024, 15:10 | Blog
Laurie H. Glimcher announced that she will assume the title of President Emerita
Who is Laurie H. Glimcher? Laurie H. Glimcher, MD, was named President and CEO of…
Sep 4, 2024, 15:08 | Blog
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
Paolo Tarantino shared a post on LinkedIn: "Two weeks to ESMO 2024. Multiple important breast…
Sep 4, 2024, 11:47 | Dialogues
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
In this episode of OncoDaily Interviews, Dr. Benjamin Schlechter, a distinguished medical oncologist at the…
Sep 3, 2024, 14:47 | Insight
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 13:49 | Insight
Article of the day, September 2nd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 08:40 | Blog
David Braun: We can make a personalized vaccine to target those tumor-specific antigens
Dana-Farber Cancer Institute shared a post on X: “'If we can identify neoantigens specific to…
Aug 31, 2024, 18:36 | Blog
Asaf Maoz: Looking Back, Facing Forward is coming up September 14th
Asaf Maoz, Medical Oncologist, Dana-Farber Cancer Institute, shared a post on X: "Looking Back, Facing…
Aug 29, 2024, 17:01 | Insight
Elad Sharon: Quite promising for c-MET over-expressing NSCLC
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Giuseppe Banna, Consultant…
Aug 29, 2024, 11:25 | Insight
Article of the day, August 29th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 29, 2024, 02:57 | Blog
Newly released ASCO principles for responsible use of AI in oncology
Toni Choueiri shared a post by Julie Gralow, adding: "Very important task force led by…
Aug 28, 2024, 13:52 | Insight
Article of the day, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
All: 417 Posts: 1 - 100
Special Coverage